false
Catalog
Psychotropic Medications in Pregnancy
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
This document is a presentation or summary of a webinar or educational session titled "Psychiatric Medications in Pregnancy." The presentation provides information on the risks and benefits of using psychotropic medications during pregnancy. It discusses the potential impact of medication exposure on the fetus, the expected physiological changes in pregnancy that can affect medication pharmacokinetics, and the importance of an individualized, patient-centered approach to treatment. The document includes information on specific medications, such as SSRIs, SNRIs, atypical antidepressants, lithium, lamotrigine, valproic acid, carbamazepine, oxcarbazepine, and antipsychotics, highlighting their risks and potential effects on the mother and baby. It also discusses the consequences of discontinuing medication during pregnancy and provides recommendations for dosing and monitoring of medications during pregnancy and postpartum. The document includes a bibliography of relevant research studies and resources for further information on medications and mental health in pregnancy. A Q&A session with the presenter is also mentioned at the end of the document.
Keywords
Psychiatric Medications in Pregnancy
risks and benefits
psychotropic medications
fetus
physiological changes in pregnancy
individualized approach
SSRIs
antipsychotics
discontinuing medication
dosing and monitoring
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English